Skip to main navigation Skip to search Skip to main content

Editorial: Commercialization and industrialization of pharmacology of infectious diseases: 2022

Research output: Contribution to journal › Editorial › Other › peer-review

Original languageEnglish
Article number1438072
Number of pages3
JournalFrontiers in Pharmacology
Volume15
DOIs
Publication statusPublished - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • augmented renal clearance
  • cefoperazone/sulbactam
  • etimicin
  • hollow fiber infection model
  • lefamulin
  • personalized antibiotic dosing
  • population pharmacokinetic (PPK)
  • teicoplanin

Cite this